Sarepta Therapeutics Inc

Common Name
Sarepta Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,372
Ticker
SRPT
Exchange
NASDAQ/NGS
Description
Sarepta Therapeutics Inc. is a biopharmaceutical company dedicated to developing precision genetic medicine for the treatment of rare neuromuscular diseases. With an emphasis on RNA-targeted therapeut...

Sarepta Therapeutics Waste Data Preview

In 2023, Sarepta Therapeutics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Sarepta Therapeutics's Waste Management data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Sarepta Therapeutics’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sarepta Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. Sarepta Therapeutics's Sustainability Report 2023
Trace every data point back to Sarepta Therapeutics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Sarepta Therapeutics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Sarepta Therapeutics generated a total of 214 metric tonnes of waste. a

Of this amount, 11.21% of Sarepta Therapeutics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 88.79% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a

Sarepta Therapeutics’s Hazardous vs Non-Hazardous Waste Over Time

20222023055110165220tonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Sarepta Therapeutics reduced the environmental impact of its waste?

Since 2023, Sarepta Therapeutics's total waste generation has increased by 43.62%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts. a

Since 2023, Sarepta Therapeutics's hazardous waste generation has increased by 19.36%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies.. a

Overall, Sarepta Therapeutics has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials. a

Want Full Access to Sarepta Therapeutics's Waste Management Dataset?
Sign Up